Speaker Details

Gil Yosipovitch, MD

Gil Yosipovitch, MD

SESSIONS

S008 Update in General Dermatology
Mar 27, 2026 • 9:00 AM - 12:00 PM • Four Seasons 3
F048 Chronic Urticaria: What's New
Mar 28, 2026 • 3:30 PM - 5:30 PM • Four Seasons 3
U093 JAAD Game Changers
Mar 30, 2026 • 7:30 AM - 8:30 AM • Bluebird 2D
F082 Itch
Mar 30, 2026 • 9:00 AM - 11:00 AM • Four Seasons 1

DISCLOSURES

AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);